NVAX Novavax, Inc.
$10.02▲ +6.60%
Healthcare
Other
After hours
$9.97▼ -0.54%
Oct 27, 5:56 PM ET
Volume 6.77M
Avg Volume (10D) 7.40M
Key Metrics & Fundamentals
Market Cap
$1.65B
P/E Ratio
–
Div Yield
0.00%
52W Range
6.20 - 13.39
% vs 50 MA
-3.14%
% vs 200 MA
8.17%
RSI-14
44.1
MACD Histogram
-0.3400
Beta (1Y vs SPY)
2.01
Free Cash Flow
-$73.40M
Gross Rev
$56.70M
Gross Profit
$42.45M
EBITDA
-$42.93M
COGS
$14.25M
Operating Exp
$97.36M
Operating Income
-$54.91M
EBIT
-$54.91M
Pretax Income
-$51.68M
Net Income
-$53.39M
EPS (Diluted)
-0.32
Price & Volume History
Loading chart…
Recent News
Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know
Zacks · Oct 26, 2026 4:45 PM ET
What Novavax Doubters Overlooked
Simply Wall St. · Oct 24, 2026 3:09 AM ET
3 small-cap stocks walking a fine line
StockStory · Oct 23, 2026 4:24 PM ET
Is Novavax (NVAX) Fully Priced Relative To Its Sales Base?
Simply Wall St. · Oct 23, 2026 3:08 PM ET
Biogen (BIIB) Surges 5.3%: Is This an Indication of Further Gains?
Zacks · Oct 23, 2026 6:19 AM ET
Stock Market Today, Oct. 22: Moderna Stock Plummets 18% on Melanoma Vaccine Data Leak Reports
Motley Fool · Oct 22, 2026 5:05 PM ET
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Zacks · Oct 21, 2026 8:00 AM ET
3 Reasons NVAX is Risky and 1 Stock to Buy Instead
StockStory · Oct 20, 2026 12:53 PM ET
Novavax (NVAX) Stock Declines While Market Improves: Some Information for Investors
Zacks · Oct 19, 2026 4:45 PM ET
Novavax shareholder Shah Capital to step back from activist role
Reuters · Oct 16, 2026 5:28 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See NVAX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.